The effectiveness of cancer treatments threatened by rising antibiotic resistance. Destiny’s XF-73 drug has potential to reduce the risk of post cancer surgery infections.
Please see link to Longitude Prize article below:-
The effectiveness of cancer treatments threatened by rising antibiotic resistance. Destiny’s XF-73 drug has potential to reduce the risk of post cancer surgery infections.
Please see link to Longitude Prize article below:-